NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • September 28th, 2012 • Lorus Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
This Non-Exclusive License Agreement (“Agreement”) is effective as of 18 April 2012 (“Effective Date”) by and between Genentech, Inc., having its principal place of business at 1 DNA Way, South San Francisco, California 94080 (hereinafter “Genentech”) and Lorus Therapeutics Inc., having its principal place of business at 2 Meridian Road, Toronto, Ontario, Canada M9W 4Z7 (hereinafter “Lorus”).
